Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Vilanterol Trifenatate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-pot method for Vilanterol intermediate fumarate. Reduces solvent waste, improves purity to >99.8%, and ensures scalable supply chain reliability for global pharma partners.
Patent CN116283512B reveals a novel synthesis route for Vilanterol Trifenatate offering high purity and reduced genotoxic impurities for reliable API supply chains.
Overcome low yield and high purification costs in vilanterol synthesis. New succinic acid salt method achieves 76% yield, 99.6% purity, and <0.1% S-isomer. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.